Range Advisory, LLC’s Amgen AMGN Stock Holding History

Range Advisory, LLC’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$608K	Buy	1,680 +470	+39%	+$161K	0.07%	137
2026 Q1	$426K	Buy	1,210 +382	+46%	+$136K	0.08%	142
2025 Q4	$271K	Buy	+828	New	+$263K	0.07%	150

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Range Advisory, LLC's AMGN Position: Q2 2026 in Review

Range Advisory, LLC increased its Amgen (AMGN) stake by 39% in Q2 2026, buying an estimated $161K and bringing the position to 1,680 shares worth $608K. The position accounts for 0.07% of the portfolio, ranked #137.

Range Advisory, LLC first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Range Advisory, LLC held 1,680 shares of Amgen worth $608K as of Q2 2026.
Range Advisory, LLC bought 470 Amgen shares in Q2 2026, an estimated $161K.
Amgen made up 0.07% of Range Advisory, LLC's portfolio in Q2 2026, its #137 holding.
Range Advisory, LLC first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Range Advisory, LLC's 13F filing for Q2 2026, filed 2 Sep 2026.